Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Beware! 3 Nasdaq Stocks Waving Massive Red Flags Right Now.
05:20am, Wednesday, 20'th Sep 2023
After a blistering run in this year's first half, the stock market has changed. Many high-flying stocks have taken a turn for the worse since the dog days of summer and are now flashing warning signs
Uninsured Americans can still get free Covid boosters — here's how to find them
11:19am, Tuesday, 19'th Sep 2023
The new Covid vaccines from Pfizer and Moderna began to roll out last week after the CDC recommended them to all Americans ages six months and up.
Moderna to cut mRNA drug substance production at Lonza facility
10:56am, Tuesday, 19'th Sep 2023
Moderna said on Tuesday it will cut production of mRNA drug substance for its COVID-19 vaccine at Lonza's facility in Switzerland this quarter as part of a plan to align manufacturing of the shots wit
2 Stocks That Sank Hard on Monday
06:49pm, Monday, 18'th Sep 2023
Short-term investors in Moderna are worried about lower expected vaccine adoption. Unity Software's new fee structure has caused some backlash.
Here Are 15 New Reasons to Be Bullish About Moderna Stock
05:15am, Monday, 18'th Sep 2023
Moderna's coronavirus vaccine revenue is tanking, and it could continue to fall. However, the company has plenty of activity ongoing in the pipeline, with new medicines on the way.
Moderna (MRNA) Receives CHMP Nod for Updated COVID Vaccine
11:17am, Friday, 15'th Sep 2023
Clinical data from studies on Moderna's (MRNA) updated COVID vaccine shows improved antibody responses against multiple circulating variants, including BA.2.86, EG.5 and FL.1.5.1 variants.
UK regulator approves Moderna's updated COVID vaccine
06:23am, Friday, 15'th Sep 2023
The UK drug regulator said on Friday it has approved an updated COVID-19 vaccine by Moderna , making it the second shot to be used in the country's vaccination campaign this autumn.
This 1 Number May Completely Change Your Opinion About Moderna
05:30am, Friday, 15'th Sep 2023
Moderna's coronavirus vaccine sales are on the decline -- but other blockbuster products may be on the way. These products should more than compensate for any lost vaccine sales.
The 3 Most Undervalued Pharma Stocks to Buy in September 2023
04:30pm, Thursday, 14'th Sep 2023
It's been a rough year to invest in pharma stocks. The industry is adjusting to a sector that is less reliant on Covid-19 vaccines and is adapting to the effects of inflation as well as pressure from
Moderna (MRNA) Posts '28 Biz View, Up 3% on Upbeat Flu Jab Data
12:46pm, Thursday, 14'th Sep 2023
Moderna's (MRNA) reformulated influenza vaccine candidate meets the primary endpoint in a late-stage study. It expects to launch up to 15 new products in the next five years.
Why COVID Vaccine Demand Might Not Be That Strong
09:37am, Thursday, 14'th Sep 2023
BA.2.86 is a new COVID variant health officials have been eyeing lately. But recent reports suggest that it may not be all that concerning.
The 7 Best Meme Stocks to Buy Now: September 2023
06:30am, Thursday, 14'th Sep 2023
Given the horrendous performance of meme kings like AMC Entertainment (NYSE: AMC ) and GameStop (NYSE: GME ) lately, searching for the best meme stocks may be the last thing on your mind right now. I
Moderna, Inc. (MRNA) R&D Day and Business Updates (Transcript)
01:29am, Thursday, 14'th Sep 2023
Moderna, Inc. (NASDAQ:MRNA ) R&D Day and Business Updates September 13, 2023 1:00 PM ET Company Participants Stephane Bancel - CEO Stephen Hoge - President Jackie Miller - SVP, Therapeutic Area Head,
'This Is Not a Covid Vaccine Company,' Moderna CEO Says
12:30am, Thursday, 14'th Sep 2023
Stephane Bancel told Barron's the company won't be defined by its Covic-19 vaccine even as it uses the same technology to develop other vaccines.
Moderna Reports Successful Trial of Flu Vaccine, Plans More Treatments Ahead
01:30pm, Wednesday, 13'th Sep 2023
Moderna (MRNA) was one of the best-performing stock in the S&P 500 as the vaccine maker reported its experimental flu shot met its primary endpoint in a Phase 3 trial.
